全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2012 

Activated Protein C Has a Protective Effect against Myocardial I/R Injury by Improvement of Endothelial Function and Activation of AKT1

DOI: 10.1371/journal.pone.0038738

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objectives Activated protein C (APC) has a protective efficacy against ischemia-reperfusion (I/R) injury in several organs. The objective of this study was to investigate effect of APC in myocardium with possible mechanism. Methods We used regional and global myocardial I/R injury models of rats. They consisted of I/R injuries (1) by ligation of left coronary artery, or (2) using Langendorff apparatus. Langendorff was used to focus the mechanism of APC excluding coagulation cascade in a working heart. Each experiment had an APC group (n = 10) and a control group with normal saline (n = 10). Injections of these solutions into rats were performed 30 minutes before the planned-I/R injury. Cardiac performance after the procedure was evaluated by echocardiography or indices with Langendorff apparatus. Coronary flow (CF) was measured in the global I/R injury model. Western blotting was performed to detect the change of AKT1 signal in myocardium after global I/R injury. Results LV function improved significantly in the APC group: %EF at 2 weeks after procedure, 70.8%±4.5% vs. 56.5%±0.7%; APC vs. control; p<0.01. Percent LV development pressure (LVDP) also improved in the APC group significantly, 88.8%±45.3% vs. 28.1%±15.4%; APC vs. control; p<0.01. In APC group, %CF improved significantly, 88.5%±15.8% vs. 65.0%±13.4%; APC vs. control; p<0.01. It was enhanced significantly when acetylcholine was administered; % CF: 103.5%±9.9% vs. 87.0%±12.1%; APC vs. control; p<0.05. Western blotting revealed that APC significantly induced activation of phosphorylated AKT1 in myocardium (p<0.05). Conclusions APC has a novel effect to protect myocardium and cardiac performance against I/R injury through improvement of endothelial function and activation of AKT1.

References

[1]  Liakopoulos OJ, Teucher N, Muhlfeld C (2006) Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment. Eur J Cardiothorac Surg 30: 263–270.
[2]  Aikawa R, Nawano M, Gu Y (2000) Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102: 2873–2879.
[3]  Mosnier LO, Zlokovic BV, Griffin JH (2007) The cytoprotective protein C pathway. Blood 109: 3161–3172.
[4]  Griffin JH, Fernandez JA, Liu D, Cheng T, Guo H, et al. (2004) Activated protein C and ischemic stroke. Crit Care Med 32: S247–253.
[5]  Mosnier LO, Griffin JH (2003) Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J 373: 65–70.
[6]  Nick JA, Coldren CD, Geraci MW (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104: 3878–3885.
[7]  Abraham E (2005) Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc 2: 243–247.
[8]  Feistritzer C, Riewald M (2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105: 3178–3184.
[9]  Yamauchi T, Sakurai M, Abe K, Takano H, Sawa Y (2006) Neuroprotective effects of activated protein C through induction of insulin-like growth factor-1 (IGF-1), IGF-1 receptor, and its downstream signal phosphorylated serine-threonine kinase after spinal cord ischemia in rabbits. Stroke 37: 1081–1086.
[10]  Guo H, Liu D, Gelbard H (2004) Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 41: 563–572.
[11]  Yamanel L, Mas MR, Comert B (2005) The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care 9: R184–190.
[12]  Mizutani A, Okajima K, Uchiba M, Noguchi T (2000) Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95: 3781–3787.
[13]  Finigan JH, Dudek SM, Singleton PA (2005) Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280: 17286–17293.
[14]  Jakson CJ, Xue M, Thompson P (2005) Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair Regen 13: 284–294.
[15]  Fernandez JA, Vento AE, Jormalainen M (2006) Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects. Cardiovasc Drugs Ther 20: 113–121.
[16]  Morissette MR, Rosenzweig A (2005) Targeting survival signaling in heart failure. Curr Opin Pharmacol 5: 165–170.
[17]  Fukui S, Kitagawa-Sakakida S, Sawa Y (2008) Therapeutic effect of midkine on cardiac remodeling in infarcted rat hearts. Ann Thirac Surg 85: 562–70.
[18]  Ono M, Sawa Y, Ryugo M (2005) BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts. Eur J Cardiothorac Surg 27: 117–121.
[19]  Chang WL, Chung CH, Wu YC, Su MJ (2004) The vascular and cardioprotective effects of liriodenine in ischemia-reperfusion injury via NO-dependent pathway. Nitric Oxide 11: 307–315.
[20]  Nagoshi T, Matsui T, Aoyama T (2005) PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115: 2128–2138.
[21]  Isobe H, Okajima K, Uchiba M (2001) Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104: 1171–1175.
[22]  Favory R, Lancel S, Marechal X, Tissier S, Neviere R (2006) Cardiovascular protective role for activated protein C during endotoxemia in rats. Intensive Care Med 32: 899–905.
[23]  Pirat B, Muderrisoglu H, Unal MT (2007) Recombinant human-activated protein C inhibits cardiomyocyte apoptosis in a rat model of myocardial ischemia-reperfusion. Coron Artery Dis 18: 61–66.
[24]  Loubele ST, Spek A, Leenders P, van Oerle R, Aberson HL, et al. (2009) Activated Protein C Protects Against Myocardial Ischemia/Reperfusion Injury via Inhibition of Apoptosis and Inflammation. Arterioscler Tromb Vasc Biol 29: 29: 1087–1092.
[25]  Uchiba M, Okajima K, Oike Y (2004) Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo. Circ Res 95: 34–41.
[26]  Joyce DE, Grinnell BW (2002) Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 30: S288–293.
[27]  Cheng T, Liu D, Griffin JH (2003) Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9: 338–342.
[28]  Matsui T, Tao J, del Monte F (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104: 330–335.
[29]  Gao F, Gao E, Yue TL (2002) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105: 1497–1502.
[30]  Gaudreault N, Perrin RM, Guo M, Clanton CP, Wu MH, et al. (2008) Counter regulatory effets of PKCβII and PKCδ on coronary endothelial permeability. Arterioscler Thromb Vas Biol 28: 1527–1533.
[31]  Rubanyi GM (1993) The role of endothelium in cardiovasucular homeostasis and diseases. J Cardiovasc Pharmacol 22: S1–14.
[32]  Swaidi JA, Hamasaki S, Higano ST (2000) Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction. Circulation 101: 948–954.
[33]  Dossumbekova A, Berdyshev EV, Gorshkova I (2008) Akt activates NOS3 and separately restores barrier integrity in H2O2-stressed human cardiac microvascular endothelium. Am J Physiol Heart Circ Physiol 295: 2417–2426.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133